Supplemental Information
The secondary structure of chLGP2 and chMDA5 are at the top and bottom respectively. Outline boxes in green, yellow, cyan, red and orange delimit the Hel1, Hel2i, Hel2, Pincer and CTD domains. Helicase conserved motifs are indicated in black on the bottom and important loops such as the Hel2i, Hel2, end-binding and capping loops are highlighted with a green, yellow, cyan, magenta or orange background respectively. Figure   made with ESPript (Gouet et al., 1999) . Sequences aligned include those from birds (chicken, Muscovy duck), mammals (human, mouse), reptile (alligator), amphibians (frog) and fish (zebrafish). Annotation is similar to Figure S1 . Table S1 for quantification).
(B) Comparison of the structures of the closed and semi-closed states of chLGP2 after superposition of the Hel1 domain. The Hel1, Hel2, Hel2i and CTD domains are coloured green (pale green), cyan (pale cyan), yellow (sand) and orange (pale orange)
for respectively and the dsRNA 5′ strand violet (pale violet) and 3′ strand yellow (sand) for the closed (semi-closed) states respectively. (A) Expression of chLGP2, chLGP2 variants and hLGP2 in chicken DF1 cells (top) and expression of hLGP2 and hLGP2 variants in human Huh7.5 cells (bottom). The protein expression of other MDA5 constructs used in this work has been previously determined and found to be comparable to that of their wt counterpart .
(B) RIG-I and MDA5-mediated endogenous response to dsRNA in human HEK293 (in blue) and Huh7.5 (in red) cells. Activation of huIFN promoter by RIG-I agonist 5′ppp-dsRNA (61mer), MDA5 agonist 6 bacteriophage 2.9, 4.1 and 6.4 kbp long dsRNA, and RIG-I/MDA5 agonist poly(I:C). Note the lack of detectable endogenous response observed in Huh7.5 cells and the neutral effect of the pCG-duF vector (noted "F") used as a complement loading DNA to ensure identical amounts of DNA in the experiments with expression vectors as a source of exogenous MDA5 and/or LGP2.
(Related to Figure 7B) (C) Enhancing effect of exogenously supplied hLGP2 on endogenous response to poly(I:C) in human HEK293 cells with the unit 1 corresponding to 5.5 ng LGP2 DNA/well. (Related to Figure 7A ).
(D) Lack of signalling ability of exogenous hLGP2 upon activation with poly(I:C) or 5′
ppp-dsRNA (left) and dose-response enhancement by hLGP2 of the activation of exogenous hMDA5 by poly(I:C) (right) in human Huh7.5 cells. Note the high constitutive activation by MDA5_1 (corresponding to 5.5 ng DNA/well) (as previously reported see and references therein, see also panel E Figure 7B ).
(E) Enhancing effect of hLGP2 on exogenous hMDA5 is observed only when transfected in limited amount and/or activated by a sub-optimal amount poly(I:C) in human Note also that the enhancing effect of hLGP2 on hMDA5 is restricted to poly(I:C) and is not observed with another MDA5 RNA agonist, the 6 bacteriophage 2.9, 4.1 and 6.4 kbp long dsRNA, while hMDA5 do respond also to this agonist in the absence of huLGP2 (compare 6 and the no (0) conditions in the upper left panel for each amount of transfected hMDA5). (Related to Figure 7B ).
(F) RNA binding deficient hLGP2 mutants (K138E/R492E or hel°, K650E/K651E or CTD°, K138E/R492E/K650E/K651E or hel°CTD°) but not ATPase-deficient E132Q mutant (see Figure 1E for ATPase activity) no longer exhibit enhancing activity for hMDA5 activated by poly(I:C) in human Huh7.5 cells (Related to Figure 7B ). Figure 7C ). LGP2 LGP2 Asn408(N,ND2) dRIG-I (4A2W) 
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Supplementary Experimental Procedures
Protein preparation chMDA5. Chicken (Gallus gallus) MDA5 constructs (Genbank: NP_001180567) full-length chMDA5 (residues 1-1001), chMDA5_CARD (residues 298-994), chMDA5CARD-Q (residues 298-994 with E436Q mutation) were cloned into pETM11 (EMBL) using a synthetic gene (GeneArt). All constructs were expressed in E. coli Rosetta 2 (Novagen) and cells were harvested and lysed by sonication in buffer containing 50 mM Tris pH 7.6, 500 mM NaCl, 10 % glycerol, 20 mM imidazole and 1 mM DTT. After centrifugation the lysate was applied to nickel-NTA-Superflow resin (QIAGEN). The protein was dialyzed against dialysis buffer (20 mM Hepes pH 7.5, 100 mM NaCl, 5% Glycerol, 1 mM DTT) at 4°C for 16 hours. The N-terminal 6-histidine-tag was cleaved with his-tagged Tobacco Etch Virus (TEV) protease during dialysis and cleaved protein repurified on nickel-NTA resin. chMDA5
constructs were further purified with a cation exchange column (HiTrap SP, GE Healthcare) and size-exclusion chromatography (Superdex 200, GE Helthcare) in a buffer containing 20 mM Hepes pH 7.5, 150 mM NaCl and 2 mM DTT.
chLGP2.
A synthetic gene (GeneArt) comprising the coding sequence of chLGP2 (Genbank: AEK21509) with an added N-terminal GGGGS linker was cloned into pETM11SUMO (EMBL). Full-length chLGP2 full length was expressed in E.coli Rosetta 2 as a Sumo fusion protein and cells were harvested and lysed by sonication in sonication buffer (50 mM Na 2 HPO 4 pH 8, 300 mM NaCl, 5% glycerol, 50 mM arginine, 5 mM β-mercapto-ethanol).
After centrifugation the lysate was applied to nickel-NTA-Superflow resin. The protein was dialyzed against sonication buffer at 4°C for 16 hours. The 6-histidine-tag and Sumo-tag was cleaved with TEV protease during dialysis. Cleaved protein was further purified with anion exchange column (HiTrap Q GE Healthcare) and size-exclusion chromatography (Superdex 200, GE Healthcare) in a buffer containing 20 mM Hepes pH 7.5, 200 mM NaCl and 250 µM TCEP (tris(2-carboxyethyl)phosphine).
hLGP2. Full-length hLGP2 (Genbank NM_024119.2) was cloned into the pETM11SUMO vector (EMBL) and expressed in E.coli and purified as for chLGP2. The chromatograph of a HiTrap Q purification shows two peaks, corresponding to hLGP2 monomers or dimers (the majority), as deduced from size-exclusion chromatography.
RIG-I.
Full-length hRIG-I was cloned into pFastBAC and expressed in HiFive insect cells.
Cells were harvested and lysed by sonication in buffer (50 mM Tris pH7.6, 500 mM NaCl, 10% glycerol, 20 mM Imidazole, 1 mM DTT). After centrifugation the lysate was applied to nickel-NTA-Superflow resin and further purified as for chLGP2. Full-length dRIG-I was purified from insect cells as described .
Crystallization
For protein crystallization, 576 different conditions were initially screened in vapour diffusion sitting drop format using a Cartesian robot. After screening, the crystal conditions were optimized in 24-well hanging drop crystallization plates.
chMDA5 1:1 complex: Directly after size exclusion chromatography chMDA5ΔCARD-Q was mixed with 10 bp dsRNA in a 1:1 molar ratio and incubated for 30 minutes on ice. The complex was concentrated using an Amicon Ultra concentrator to around 10 mg/ml and 2 mM AMPPNP (adenosine 5′-(β,γ-imido)triphosphate lithium salt hydrate ) was added.
Sample and reservoir buffer (0.025 M Bis-Tris pH 6.5, 0.075 M succinic acid pH 7.0, 12-14% PEG 3350, 2% sucrose) were mixed in a 2:1 ratio. Three hours after setup, cover glasses with drops were transferred from a reservoir containing 12-14% PEG 3350 to one containing 8% PEG 3350. Crystals grew in one week at 20°C and were harvested in cryo-protectant solution (0.025 M Bis-Tris pH 6.5, 0.075 M succinic acid pH 7.0, 25% 3350, 10% ethylene glycol) before flash freezing with liquid nitrogen.
chMDA5 2:1 complexes: Directly after size exclusion chromatography chMDA5ΔCARD-Q was mixed with 24, 26 or 27 bp dsRNA in a 0.5:1 molar ratio and incubated for 30 minutes dsRNA in a 1:1 ratio. The sample was applied onto a glow-discharged quantifoil grid 400 mesh 3.5/1 (Quantifoil Micro Tools GmbH, Germany), the excess solution was blotted for 2 s with a Vitrobot (FEI) and the grid frozen in liquid ethane. Data collection was performed on a FEI Polara microscope operated at 300 kV. Fifty cryoEM micrographs were manually collected on a K2 summit electron direct detector (Gatan) at a magnification of 20,000×, giving a pixel size of 0.97 Å. Movies of 6 frames were collected with a total exposure time of 6 s and a total dose of 30e -/Å 2 . The contrast transfer function (CTF) for each micrograph was determined with CTFFIND3 (Mindell and Grigorieff, 2003) and showed defocuses between 2.2 and 3.8 µm. A total of 7185 overlapping segments of MDA5 and 3153 overlapping segments of LGP2 (400 pixels long) were picked using EMAN boxer (Ludtke et al., 1999) with a shift of 64 pixels between adjacent segments. Corresponding segments were suggested to 2D classification in Relion1.3 (Scheres, 2012) . Power spectra were calculated from masked 2D class averages.
Fluorescence polarisation anisotropy
dsRNAs used for anisotropy experiments were formed by annealing the following separate strands for 1 min at 95 °C and cooling down on ice in a buffer containing 20 mM Hepes, 2 mM EDTA at pH 6.8 (see also Figure S5 for RNA sequences):
12-mer dsRNA : 5′-FAM CAUGUGGAGCCC-3′ and 5′-OH GGGCUCCACAUG-3′, 12-mer dsRNAppp : 5′-FAM CAUGUGGAGCCC-3′ and 5′-ppp GGGCUCCACAUG-3, 3′ overhang dsRNA : 5′-OH GGCCAGUGCGAA-3′ and 5′-FAM CGCACUGGCCAA-3′, 5′ overhang dsRNA : 5′-OH AACCGGUCACGC3′ and 5′-OH AAGCGUGACCGG FAM -3′.
Anisotropy measurements were performed at room temperature using a multimodular fluorometer (Quantamaster QM4CW; Manufacturer: Photon Technology International).
RNA concentration was adjusted to 2.5 nM (12-mer 5′ppp-dsRNA) or 5 nM (12-mer 5′OH-dsRNA, 3′ 2 nt overhang dsRNA and 5′ 2 nt overhang dsRNA for LGP2 measurements), 13 or 50 nM (12-mer 5′OH-dsRNA for MDA5 measurements) by mixing in the cuvette with buffer (20 mM Hepes pH 7.5 150 mM NaCl, 200 µM TCEP, 4 mM MgCl 2 ). Protein was titrated into the cuvette and incubated for 5 minutes before measurements. The total volume of titrated protein was less than 10% of the final volume. Anisotropy measurements were made with excitation wavelength 495 nm and emission wavelength 515 nm for 100 seconds.
Experiments were performed more than three times per system. Binding data was analysed by The experimental anisotropy (y), Initial anisotropy (b), the maximum anisotropy (m), the RNA concentration (R), and the protein concentration (P), equilibrium binding constant (Kd) and hill coefficient (n).Rig-I measurement curves are fitted with n=1 and the value of n are written in Figure S4 . The error bars represent the S.D. value of at least three individual experiments.
ATPase activity assays
ATPase reactions were monitored using a Malachite green assay kit (Bioassays) over 0.5-30 min time courses. All proteins were pre-incubated with 4-fold molar excess of dsRNA for 10 minutes at 28 °C in ATP hydrolysis buffer (20 mM Hepes pH7.5, 100 mM NaCl, 1%
glycerol, 2 mM DTT, 4 mM MgCl 2 ). The reaction was initiated by adding 2 mM ATP. For determination of kinetic parameters, the ATP concentration was varied from 0.125 to 10 mM.
The reactions were quenched at 5 time points between 30 seconds to 4 minutes. The 10 µl reaction aliquots were quenched by mixing with 10 µl of quenching buffer (20 mM Hepes pH 7.5, 100 mM NaCl, 1% glycerol, 2 mM DTT, 100 mM EDTA). 80 µl of 5 times diluted
Malachite green solution was added and developed for 30 minutes at room temperature. The absorbance at 622 nm was measured with a plate reader. For each ATP concentration, the
